NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2017 to Q4 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $339K, a 9.91% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $1.38M, a 23.4% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Share-based Payment Arrangement, Expense for 2024 was $1.34M, a 21.6% increase from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Share-based Payment Arrangement, Expense for 2023 was $1.11M, a 16.7% increase from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Share-based Payment Arrangement, Expense for 2022 was $947K, a 47.2% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $1.38M $339K +$30.6K +9.91% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-12
Q3 2024 $1.34M $340K +$69.1K +25.5% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-17
Q2 2024 $1.28M $339K +$42.2K +14.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.23M $357K +$119K +50.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.11M $309K +$8.46K +2.82% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-12
Q3 2023 $1.11M $271K +$15.4K +6.01% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-17
Q2 2023 $1.09M $296K +$40.9K +16% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.05M $238K +$4.91K +2.11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.04M $300K +$97.1K +47.8% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $947K $256K -$86.3K -25.2% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-15
Q2 2022 $1.03M $256K -$623K -70.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.66M $233K -$93.6K -28.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1.75M $203K -$42.8K -17.4% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 $1.79M $342K +$9.33K +2.8% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-22
Q2 2021 $1.78M $879K +$495K +129% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $1.29M $326K -$205K -38.6% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $1.49M $246K -$342K -58.2% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $1.84M $333K +$262K +372% Jul 1, 2020 Sep 30, 2020 10-K/A 2022-05-31
Q2 2020 $1.57M $384K +$152K +65.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $1.42M $532K +$462K +657% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $960K $588K +$469K +394% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $492K $70.5K Jul 1, 2019 Sep 30, 2019 10-K 2020-12-09
Q2 2019 $232K +$113K +94.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $70.2K -$184K -72.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $119K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q2 2018 $120K +$108K +909% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $254K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 $64.9K Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $11.8K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.